Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs . Founded by Kate Cameron in 2017, Cytochroma is backed by Innovate UK, Scottish Enterprise, Angel Academe, Cambridge Capital Group, and Investing Women and is headquartered in Edinburgh.